CD8A and melanoma: Before, it has been studied the β3-ARs’ role in the immune response of melanoma, where both SR59230A and propranolol neutralized melanoma growth in vivo and their effect were associated with a considerable increase in NK and CD8 cells, a strong reduction in Treg cells and MDSC within the tumor mass [156].